Last reviewed · How we verify
Placebo - Cap
Placebo produces no pharmacological effect and works through psychological expectation and the placebo response.
Placebo produces no pharmacological effect and works through psychological expectation and the placebo response. Used for Clinical trial control / comparator.
At a glance
| Generic name | Placebo - Cap |
|---|---|
| Also known as | Calcined magnesium, Placebo, placebo, Placebo vaginal capsule, Study Drug |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo is an inert substance with no active pharmaceutical ingredient. Its therapeutic effects, when observed, arise from patient expectation, conditioning, and psychobiological mechanisms rather than direct molecular action. It is commonly used as a control in clinical trials to measure the true efficacy of active drugs.
Approved indications
- Clinical trial control / comparator
Common side effects
- Nocebo effects (adverse events attributed to placebo expectation)
Key clinical trials
- Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease (NA)
- The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. (NA)
- Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype (NA)
- Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression (PHASE1, PHASE2)
- Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007) (PHASE3)
- IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes (PHASE3)
- A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010) (PHASE3)
- Effect of L. Reuteri LM1063 on Sleep Health Improvement (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo - Cap CI brief — competitive landscape report
- Placebo - Cap updates RSS · CI watch RSS
- Ain Shams University portfolio CI